Broad Sky Partners today announced a strategic investment from Capital Constellation, as well as its acquisition of Thomas Scientific, marking the team’s first transaction. As a private equity firm that partners with leading middle market business services and consumer companies, Broad Sky offers a differentiated approach to sector-focused, thematic investing and value creation.

The firm was founded and is led by Chief Executive Officer Tyler Zachem, a 29-year private equity veteran, who most recently served as Co-Head of Carlyle Global Partners, Carlyle’s long-dated investment strategy, and Co-Chair of the Investment Committee of CEOF, Carlyle’s U.S. middle market platform. He originally started Broad Sky in 2014, joined Carlyle for over five years and has now returned to build Broad Sky with Partners Adam Glucksman, Jodi Kahn and Jonathan Marlow, who have worked together alongside Zachem and also one another, in some cases for over a decade, as successful investors and operators.

“Broad Sky today is founded on the strength of its people and the power of its connections,” said Zachem. “Our team of 23 professionals offers a diverse set of talent and perspectives, which includes a highly experienced investment team with a deep sector focus and a robust, dedicated Portfolio Resource Group. We strive to be a great partner to all our constituents.”

Strategic Investment from Capital Constellation
Broad Sky has received a strategic investment from Capital Constellation, a group of premier global institutional investors who, together with Capital Constellation’s affiliated funds (collectively, “Constellation”), provide catalytic investment capital and expertise to growing investment management platforms and is managed by private equity and alternative investment manager, Wafra Inc. (“Wafra”).

Daniel Adamson, President of Constellation, said, “We are delighted to partner with Broad Sky, who not only bring a wealth of sector-focused experience, but also are looking to build a world class firm.”

Gustavo Cardenas, a Managing Director at Wafra, also noted, “Broad Sky has already built a deep and cohesive team that is well equipped to target and execute within the business services and consumer industries. Working alongside them on initial opportunities and their growth plans make us excited about being a long-term partner with the Broad Sky team.”

The partnership with Broad Sky reflects Constellation’s strategy of providing growth and investment capital for investor entrepreneurs and accelerating business development by promoting peer-to-peer collaboration among leading institutional investors and investment managers.

Thomas Scientific Acquisition
Broad Sky is also announcing that it has acquired Thomas Scientific from Carlyle, marking the firm’s first investment. Thomas Scientific is a leading pure-play solutions provider of critical supplies to the healthcare, biotech, clinical diagnostics and life sciences industries.

Charles Simmons, President & Chief Executive Officer of Thomas Scientific, commented, “We’re grateful to Carlyle for their support since 2017 and excited to partner with Broad Sky for the next phase of our expansion. We’ve known the partners at Broad Sky for several years, given their investment and operating roles during their time at Carlyle. They have the right mix of skills and resources to help us grow and continue to advance our mission to be the most trusted partner in science for our customers, suppliers and associates.”

Adam Glucksman, Partner at Broad Sky, added, “We’ve identified several powerful, long-term drivers of growth in life sciences and clinical diagnostics, and believe Thomas Scientific has a platform that is uniquely positioned for significant expansion through organic growth as well as strategic acquisitions. We’re thrilled to partner with their talented management team and look forward to helping the company scale.”

As part of its governance structure, Lynn Calpeter, a Broad Sky Operating Partner and former General Electric finance executive, will chair the board.

Berenson & Co. served as financial advisor and Morrison Cohen LLP served as legal advisor to Broad Sky.

About Broad Sky Partners
Broad Sky Partners is a private equity firm that partners with leading middle market business services and consumer companies. The firm offers a differentiated approach to sector-focused, thematic investing and value creation. Its Portfolio Resource Group is dedicated to helping companies capitalize on growth opportunities. Broad Sky was founded in 2014 and is based in New York City. To learn more, visit

About Capital Constellation
Constellation unites the expertise and capital base of premier institutional investors around the world with growth-oriented alternative asset managers. By providing strategic and financial support alongside a substantial, stable capital base, Constellation seeks to catalyze investor entrepreneurs for the long-term benefit of its members, who include the Alaska Permanent Fund, the Public Institution for Social Security of Kuwait, the New York State Common Retirement Fund, Railpen, the Kuwait Investment Authority, and the Third Swedish National Pension Fund. Since its inception, Constellation has partnered with nine managers across North America and Europe and a range of asset classes and strategies spanning technology, renewable energy, healthcare, communications, real estate and private credit. For more information, please visit:

About Wafra
Wafra is a global alternative investment manager. Wafra manages assets and commitments of approximately $28 billion (estimated as of September 30, 2021). Funds advised by Wafra have made 23 minority partnerships with both growth stage and mature alternative investment management firms. By providing flexible and accretive capital solutions and focusing on long-term partnerships, Wafra aligns and partners with high quality management teams. Headquartered in New York, Wafra and its affiliated and associated firms have additional offices in London, Kuwait and Bermuda. For more information, please visit:

About Thomas Scientific
Founded in 1900, Thomas Scientific provides the latest in supplies, equipment and supply chain solutions to the scientific community – supporting all laboratory research, biopharmaceutical, medical device, clinical diagnostics, cleanroom and other related end markets. In accordance with our mission to be the most trusted partner in science for our customers, suppliers and associates, we deliver individualized service and a comprehensive product portfolio at competitive prices, combined with customized supply chain service solutions. To learn more, visit